2000
DOI: 10.1046/j.1460-9568.2000.00930.x
|View full text |Cite
|
Sign up to set email alerts
|

Connective tissue growth factor: a novel player in tissue reorganization after brain injury?

Abstract: Recent studies have suggested a role of connective tissue growth factor (CTGF) in repair processes of the skin as well as in various types of fibrotic disease. However, a function of this molecule in central nervous system (CNS) repair has not been demonstrated yet. In this study we analysed the temporal and spatial expression pattern of CTGF after unilateral kainic acid lesions of the hippocampal CA3 region in mice. We found a strong induction of CTGF mRNA and protein expression in neurons and glial cells of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
47
1
3

Year Published

2000
2000
2013
2013

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 57 publications
(53 citation statements)
references
References 25 publications
2
47
1
3
Order By: Relevance
“…CTGF is found to occur at elevated levels in a variety of fibrotic pathologies, including the fibrous stroma of mammary tumors (Frazier and Grotendorst, 1997), chronic pancreatitis (di Mola et al, 1999), cataract formation (Wunderlich et al, 2000), nephropathy (Ito et al, 1998;Wang et al, 2001), systemic sclerosis (Sato et al, 2000), pulmonary fibrosis (Lasky et al, 1998;Sato et al, 2000), inflammatory bowel disease (Dammeier et al, 1998), bladder fibrosis due to outlet obstruction (Chaqour et al, 2002), brain fibrosis following injury (Hertel et al, 2000), atherosclerosis (Fan et al, 2000), and fibrotic skin disorders (Igarashi et al, 1996). CTGF alone does not promote fibrosis.…”
Section: Ctgf and Fibrosismentioning
confidence: 99%
“…CTGF is found to occur at elevated levels in a variety of fibrotic pathologies, including the fibrous stroma of mammary tumors (Frazier and Grotendorst, 1997), chronic pancreatitis (di Mola et al, 1999), cataract formation (Wunderlich et al, 2000), nephropathy (Ito et al, 1998;Wang et al, 2001), systemic sclerosis (Sato et al, 2000), pulmonary fibrosis (Lasky et al, 1998;Sato et al, 2000), inflammatory bowel disease (Dammeier et al, 1998), bladder fibrosis due to outlet obstruction (Chaqour et al, 2002), brain fibrosis following injury (Hertel et al, 2000), atherosclerosis (Fan et al, 2000), and fibrotic skin disorders (Igarashi et al, 1996). CTGF alone does not promote fibrosis.…”
Section: Ctgf and Fibrosismentioning
confidence: 99%
“…Others have also reported significant induction of neuronal damage in the CA3 and CA1 subregions of the hippocampus in C57BL/6 mice in response to kainate-induced seizures. 85,86 Thus, it is not clear why Schauwecker and Steward failed to It is well recognized that there is a substantial genetic variability among the 129 substrains with documented phenotypic differences. 88 The variable contribution from the C57BL/6 background in the two p53 knock-out mouse strains in combination with other variations in the genetic make-up of the mice used in these experiments make it difficult to draw firm conclusions regarding the role of the purported protective genes in kainic acid-induced neuronal damage seen with one p53 knock-out mouse strain but not the other.…”
Section: The Relationship Between P53 Expression and Neuronal Cell Deathmentioning
confidence: 99%
“…Throughout the central nervous system, CTGF protein is found in astrocytes, as well as in neuronal cells of the cortex, where it supposedly mediates TGF-␤-related functions in cell growth, development, and tissue remodeling following injury (67,68). NOVR was expressed in cortical layers II/III, V, and VI, in the CA1-CA3 hippocampus region and the amygdala, which are major parts of the basal forebrain cholinergic system, but its expression did not change in response to mAChR stimulation.…”
Section: Fig 5 Muscarinic Receptor Subtypes Differently Inducementioning
confidence: 99%